Comparison of Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens for prosthetIc vAlve Thrombosis

NACompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

January 31, 1993

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Prosthetic Valve Thrombosis
Interventions
DRUG

Streptokinase

3-hour infusion of 1.5 million units of streptokinase (16 patients, 16 episodes), repeat once 24 hours later if needed (maximum total dose 3 million units)

DRUG

Streptokinase

24-hour infusion of 1.5 million units of streptokinase (41 patients, 41 episodes), repeat once 24 hours later if needed (maximum total dose 3 million units).

DRUG

Tissue plasminogen activator

5-hour infusion of 90 mg t-PA (Tissue plasminogen activator) after 10 mg bolus (10 patients, 12 episodes), repeat once 24 hours later if needed (maximum total dose 200 mg)

DRUG

Tissue Plasminogen Activator

6-hour infusion of 50 mg t-PA (Tissue plasminogen activator) without bolus (27 patients, 27 episodes), repeat once 24 hours later up to 3 times if needed (maximum total dose 150 mg).

DRUG

Tissue Plasminogen Activator

6-hour infusion of 25 mg t-PA (Tissue plasminogen activator) without bolus (108 patients, 124 episodes), repeat once 24 hours later up to 6 times if needed (maximum total dose 150 mg).

Trial Locations (1)

34844

Kosuyolu Kartal Heart Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital

OTHER_GOV

NCT01451320 - Comparison of Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens for prosthetIc vAlve Thrombosis | Biotech Hunter | Biotech Hunter